Skip to main content
Erschienen in: Diabetologia 3/2008

01.03.2008 | Article

USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study

verfasst von: K. Auro, K. Kristiansson, B. Zethelius, C. Berne, L. Lannfelt, M.-R. Taskinen, M. Jauhiainen, M. Perola, L. Peltonen, A.-C. Syvänen

Erschienen in: Diabetologia | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Genetic variants of upstream transcription factor 1 (USF1) have previously been associated with dyslipidaemias in family studies. Our aim was to further address the role of USF1 in metabolic syndrome and cardiovascular traits at the population level in a large Swedish male cohort (n = 2,322) with multiple measurements for risk factors during 32 years of follow-up.

Methods

Participants, born in 1920–1924, were examined at 50, 60, 70 and 77 years of age. The follow-up period for cardiovascular events was 1970–2002. We genotyped three haplotype tagging polymorphisms capturing the major allelic variants of USF1.

Results

SNP rs2774279 was associated with the metabolic syndrome. The minor allele of rs2774279 was less common among individuals with metabolic syndrome than among healthy controls [p = 0.0029 when metabolic syndrome was defined according to the National Cholesterol Education Program Adult Treatment Panel III; p = 0.0073 when defined according to the International Diabetes Federation (IDF)]. The minor allele of rs2774279 was also associated with lower BMI, lower fasting glucose values and higher HDL-cholesterol concentrations in longitudinal analyses. With SNP rs2073658, a borderline association with metabolic syndrome was observed (p = 0.036, IDF), the minor allele being the risk-increasing allele. The minor allele of rs2073658 also associated with higher total and LDL-cholesterol, apolipoprotein B-100 and lipoprotein(a) concentrations in longitudinal analyses. Importantly, these trends with respect to the allelic variants prevailed throughout the follow-up time of three decades.

Conclusions/interpretation

Our results suggest that USF1 variants associate with the metabolic syndrome at population level and influence the cardiovascular risk factors throughout adulthood in a consistent, longitudinal manner.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23:469–480PubMedCrossRef Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23:469–480PubMedCrossRef
2.
Zurück zum Zitat Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) JAMA 285:2486–2497 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) JAMA 285:2486–2497
3.
Zurück zum Zitat Definition, diagnosis and classification of diabetes mellitus and its complications (1999) Report of a WHO Consultation. WHO/NCD/NCS/99.2. WHO, Geneva Definition, diagnosis and classification of diabetes mellitus and its complications (1999) Report of a WHO Consultation. WHO/NCD/NCS/99.2. WHO, Geneva
4.
Zurück zum Zitat Balkau B, Charles MA, Drivsholm T et al (2002) Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28:364–376PubMed Balkau B, Charles MA, Drivsholm T et al (2002) Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28:364–376PubMed
5.
Zurück zum Zitat Lakka HM, Laaksonen DE, Lakka TA et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716PubMedCrossRef Lakka HM, Laaksonen DE, Lakka TA et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716PubMedCrossRef
6.
Zurück zum Zitat Shoulders CC, Naoumova RP (2004) USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome. Trends Mol Med 10:362–365PubMedCrossRef Shoulders CC, Naoumova RP (2004) USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome. Trends Mol Med 10:362–365PubMedCrossRef
7.
Zurück zum Zitat Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J (2005) The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12:295–300PubMed Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J (2005) The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12:295–300PubMed
8.
Zurück zum Zitat Sundstrom J, Riserus U, Byberg L, Zethelius B, Lithell H, Lind L (2006) Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. Br Med J 332:878–882CrossRef Sundstrom J, Riserus U, Byberg L, Zethelius B, Lithell H, Lind L (2006) Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. Br Med J 332:878–882CrossRef
9.
Zurück zum Zitat Pajukanta P, Lilja HE, Sinsheimer JS et al (2004) Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet 36:371–376PubMedCrossRef Pajukanta P, Lilja HE, Sinsheimer JS et al (2004) Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet 36:371–376PubMedCrossRef
10.
Zurück zum Zitat Huertas-Vazquez A, Aguilar-Salinas C, Lusis AJ et al (2005) Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1. Arterioscler Thromb Vasc Biol 25:1985–1991PubMedCrossRef Huertas-Vazquez A, Aguilar-Salinas C, Lusis AJ et al (2005) Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1. Arterioscler Thromb Vasc Biol 25:1985–1991PubMedCrossRef
11.
Zurück zum Zitat van der Vleuten GM, Isaacs A, Hijmans A, van Duijn CM, Stalenhoef AF, de Graaf J (2007) The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia. J Lipid Res 48:193–200PubMedCrossRef van der Vleuten GM, Isaacs A, Hijmans A, van Duijn CM, Stalenhoef AF, de Graaf J (2007) The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia. J Lipid Res 48:193–200PubMedCrossRef
12.
Zurück zum Zitat Ng MC, Miyake K, So WY et al (2005) The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population. Diabetologia 48:2018–2024PubMedCrossRef Ng MC, Miyake K, So WY et al (2005) The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population. Diabetologia 48:2018–2024PubMedCrossRef
13.
Zurück zum Zitat Gibson F, Hercberg S, Froguel P (2005) Common polymorphisms in the USF1 gene are not associated with type 2 diabetes in French Caucasians. Diabetes 54:3040–3042PubMedCrossRef Gibson F, Hercberg S, Froguel P (2005) Common polymorphisms in the USF1 gene are not associated with type 2 diabetes in French Caucasians. Diabetes 54:3040–3042PubMedCrossRef
14.
Zurück zum Zitat Coon H, Xin Y, Hopkins PN, Cawthon RM, Hasstedt SJ, Hunt SC (2005) Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides. Hum Genet 117:444–451PubMedCrossRef Coon H, Xin Y, Hopkins PN, Cawthon RM, Hasstedt SJ, Hunt SC (2005) Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides. Hum Genet 117:444–451PubMedCrossRef
15.
Zurück zum Zitat Komulainen K, Alanne M, Auro K et al (2006) Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies. PLoS Genet 2:e69PubMedCrossRef Komulainen K, Alanne M, Auro K et al (2006) Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies. PLoS Genet 2:e69PubMedCrossRef
16.
Zurück zum Zitat Zeggini E, Damcott CM, Hanson RL et al (2006) Variation within the gene encoding the upstream stimulatory factor 1 does not influence susceptibility to type 2 diabetes in samples from populations with replicated evidence of linkage to chromosome 1q. Diabetes 55:2541–2548PubMedCrossRef Zeggini E, Damcott CM, Hanson RL et al (2006) Variation within the gene encoding the upstream stimulatory factor 1 does not influence susceptibility to type 2 diabetes in samples from populations with replicated evidence of linkage to chromosome 1q. Diabetes 55:2541–2548PubMedCrossRef
17.
Zurück zum Zitat Putt W, Palmen J, Nicaud V et al (2004) Variation in USF1 shows haplotype effects, gene:gene and gene:environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Hum Mol Genet 13:1587–1597PubMedCrossRef Putt W, Palmen J, Nicaud V et al (2004) Variation in USF1 shows haplotype effects, gene:gene and gene:environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Hum Mol Genet 13:1587–1597PubMedCrossRef
18.
Zurück zum Zitat Dunder K, Lind L, Zethelius B, Berglund L, Lithell H (2004) Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM). Am Heart J 148:596–601PubMedCrossRef Dunder K, Lind L, Zethelius B, Berglund L, Lithell H (2004) Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM). Am Heart J 148:596–601PubMedCrossRef
19.
Zurück zum Zitat Skarfors ET, Selinus KI, Lithell HO (1991) Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. Br Med J 303:755–760CrossRef Skarfors ET, Selinus KI, Lithell HO (1991) Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. Br Med J 303:755–760CrossRef
20.
Zurück zum Zitat Hsu TM, Chen X, Duan S, Miller RD, Kwok PY (2001) Universal SNP genotyping assay with fluorescence polarization detection. Biotechniques 31:560, 562, 564–568, passimPubMed Hsu TM, Chen X, Duan S, Miller RD, Kwok PY (2001) Universal SNP genotyping assay with fluorescence polarization detection. Biotechniques 31:560, 562, 564–568, passimPubMed
22.
Zurück zum Zitat Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265PubMedCrossRef Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265PubMedCrossRef
23.
Zurück zum Zitat Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169PubMedCrossRef Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169PubMedCrossRef
24.
Zurück zum Zitat Prentice R (1986) A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73:1–11CrossRef Prentice R (1986) A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73:1–11CrossRef
25.
Zurück zum Zitat Austin MA, Edwards KL, McNeely MJ (2004) Heritability of multivariate factors of the metabolic syndrome in nondiabetic Japanese Americans. Diabetes 53:1166–1169PubMedCrossRef Austin MA, Edwards KL, McNeely MJ (2004) Heritability of multivariate factors of the metabolic syndrome in nondiabetic Japanese Americans. Diabetes 53:1166–1169PubMedCrossRef
26.
Zurück zum Zitat Lin HF, Boden-Albala B, Juo SH, Park N, Rundek T, Sacco RL (2005) Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia 48:2006–2012PubMedCrossRef Lin HF, Boden-Albala B, Juo SH, Park N, Rundek T, Sacco RL (2005) Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia 48:2006–2012PubMedCrossRef
27.
Zurück zum Zitat Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359PubMedCrossRef Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359PubMedCrossRef
28.
Zurück zum Zitat Naukkarinen J, Gentile M, Soro-Paavonen A (2005) USF1 and dyslipidemias: converging evidence for a functional intronic variant. Hum Mol Genet 14:2595–2605PubMedCrossRef Naukkarinen J, Gentile M, Soro-Paavonen A (2005) USF1 and dyslipidemias: converging evidence for a functional intronic variant. Hum Mol Genet 14:2595–2605PubMedCrossRef
29.
Zurück zum Zitat Goldin LR, Camp NJ, Keen KJ et al (2003) Analysis of metabolic syndrome phenotypes in Framingham Heart Study families from Genetic Analysis Workshop 13. Genet Epidemiol 25 (Suppl 1):S78–S89PubMedCrossRef Goldin LR, Camp NJ, Keen KJ et al (2003) Analysis of metabolic syndrome phenotypes in Framingham Heart Study families from Genetic Analysis Workshop 13. Genet Epidemiol 25 (Suppl 1):S78–S89PubMedCrossRef
Metadaten
Titel
USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study
verfasst von
K. Auro
K. Kristiansson
B. Zethelius
C. Berne
L. Lannfelt
M.-R. Taskinen
M. Jauhiainen
M. Perola
L. Peltonen
A.-C. Syvänen
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 3/2008
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0892-9

Weitere Artikel der Ausgabe 3/2008

Diabetologia 3/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.